Rosetta Genomics (FRA:RQ1) Total Inventories : €0.00 Mil (As of Jun. 2017)

View and export this data going back to 2014. Start your Free Trial

What is Rosetta Genomics Total Inventories?

Rosetta Genomics's total inventories for the quarter that ended in Jun. 2017 was €0.00 Mil. Rosetta Genomics's average total inventories from the quarter that ended in Dec. 2016 to the quarter that ended in Jun. 2017 was €0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Rosetta Genomics's Net-Net Working Capital per share for the quarter that ended in Jun. 2017 was €-1.18.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Rosetta Genomics's Days Inventory for the three months ended in Jun. 2017 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Rosetta Genomics's Inventory-to-Revenue for the quarter that ended in Jun. 2017 was 0.00.

Rosetta Genomics Total Inventories Historical Data

The historical data trend for Rosetta Genomics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rosetta Genomics Total Inventories Chart

Rosetta Genomics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Total Inventories

Get a 7-Day Free Trial

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
Total Inventories	Get a 7-Day Free Trial															-	-	-	-	-

Rosetta Genomics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Rosetta Genomics (FRA:RQ1) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Rosetta Genomics's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2017 is

	Net-Net Working Capital Per Share (Q: Jun. 2017 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.179	+	0.75 * 0.42	+	0.5 * 0	-	4.546
-	0	-	0)	/	2.58809
=	-1.18

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Rosetta Genomics's Days Inventory for the three months ended in Jun. 2017 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2017 )	/	Cost of Goods Sold (Q: Jun. 2017 )	*	Days in Period
	=	0	/	0.506	*	365 / 4
	=	0.00

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Rosetta Genomics's Inventory Turnover for the quarter that ended in Jun. 2017 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2017 )	/	Average Total Inventories (Q: Jun. 2017 )
	=	0.506	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Rosetta Genomics's Inventory to Revenue for the quarter that ended in Jun. 2017 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2017 )	/	Revenue (Q: Jun. 2017 )
	=	0	/	0.774
	=	0.00

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Rosetta Genomics Total Inventories Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (FRA:RQ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rosetta Genomics Ltd (FRA:RQ1) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Plaut Street, Science Park, Rehovot, ISR, 76706

Website

http://www.rosettagenomics.com

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Rosetta Genomics (FRA:RQ1) Headlines

No Headlines